IP Library › Assignment 063074/0112
Patent Assignment
Reel/Frame 063074/0112

Assignment of Assignor's Interest

Recorded: 2023-03-23 Pages: 7
Assignor
CADENT THERAPEUTICS, INC.
Executed: 2022-12-01
Assignee
NOVARTIS AG
LICHTSTRASSE 35, BASEL, 4056, SWITZERLAND
Covered Properties (2)
Thienopyrimidinone Nmda Receptor Modulators and Uses Thereof
Application: 16/060,267 →
Publication: US 2018/0360837
Thienopyrimidinone Nmda Receptor Modulators and Uses Thereof
Application: 17/186,137 →
Publication: US 2022/0016117
Related Assignments (2)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 4, 2019
From: ANDERSON, DAVID R.; VOLKMANN, ROBERT A.; MENNITI, FRANK S.; FANGER, CHRISTOPHER
To: CADENT THERAPEUTICS, INC.
Reel/Frame 047899/0658 →
Assignment of Assignor's Interest Oct 25, 2021
From: ANDERSON, DAVID R.; VOLKMANN, ROBERT A.; MENNITI, FRANK S.; FANGER, CHRISTOPHER
To: CADENT THERAPEUTICS, INC.
Reel/Frame 057892/0296 →